Tag Archives:monoclonal antibody
Focusing on non-tumor-derived factors for leukemia therapy
Approximately 10-20 million people worldwide are estimated to be infected with human T-cell leukemia virus type I (HTLV-I), and 1-3% of HTLV-I-infected individuals develop a cancer of CD4+ T lymphocytes in the blood each year. The retrovirus-associated
